Publication

Inhibition of the prohormone convertase subtilisin-kexin isoenzyme-1 induces apoptosis in human melanoma cells

Weiß, N.
; 
Stegemann, A.
; 
Elsayed, Marwa A.T.A.
; 
Schallreuter, Karin U.
; 
Luger, T.A.
; 
Loser, K.
; 
Metze, D.
; 
Weishaupt, C.
; 
Böhm, M.
Publication Date
2014
End of Embargo
Supervisor
Keywords
Prohormone convertases, PCs, Endoproteases, Apoptosis, Human melanoma cells, Melanoma therapy
Rights
Peer-Reviewed
Yes
Open Access status
closedAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Life Sciences Publications
Show all metadata
Additional title
Abstract
Prohormone convertases (PCs) are endoproteases that process many substrates in addition to hormone precursors. Although overexpression of PCs is linked to carcinogenesis in some solid tumors, the role of subtilisin-kexin isoenzyme-1 (SKI-1) in this context is unknown. We show that SKI-1 is constitutively expressed in human pigment cells with higher SKI activity in seven out of eight melanoma cell lines compared with normal melanocytes. SKI-1 immunoreactivity is also detectable in tumor cells of melanoma metastases. Moreover, tissue samples of the latter display higher SKI-1 mRNA levels and activity than normal skin. From various stimuli tested, 12-O-tetradecanoylphorbol-13-acetate and tunicamycin affected SKI-1 expression. Importantly, SKI-1 inhibition by the cell-permeable enzyme inhibitor decanoyl-RRLL-chloromethylketone (dec-RRLL-CMK) not only suppressed proliferation and metabolic activity of melanoma cells in vitro but also reduced tumor growth of melanoma cells injected intracutaneously into immunodeficient mice. Mechanistic studies revealed that dec-RRLL-CMK induces classical apoptosis of melanoma cells in vitro and affects expression of several SKI-1 target genes including activating transcription factor 6 (ATF6). However, ATF6 gene silencing does not result in apoptosis of melanoma cells, suggesting that dec-RRLL-CMK induces cell death in an ATF6-independent manner. Our findings encourage further studies on SKI-1 as a potential target for melanoma therapy.
URI
http://hdl.handle.net/10454/7065
Version
No full-text in the repository
Citation
Weiß N, Stegemann A, Elsayed MA, Schallreuter KU, Luger TA, Loser K, Metze D, Weishaupt C and Böhm M (2014) Journal of Investigative Dermatology. 134 (1):168-75.
Link to publisher’s version
Link to published version
Link to Version of Record
https://doi.org/10.1038/jid.2013.282
Type
Article
Qualification name
Notes